United-Guardian, Inc. (NASDAQ:UG) Stock Short Interest Falls 39.1%

United-Guardian, Inc. (NASDAQ:UG) saw a large drop in short interest during the month of October. As of October 15th, there was short interest totaling 7,555 shares, a drop of 39.1% from the September 30th total of 12,413 shares. Based on an average daily volume of 13,933 shares, the short-interest ratio is presently 0.5 days. Currently, 0.2% of the shares of the company are sold short.

United-Guardian Price Performance

United-Guardian stock opened at $7.07 on Friday. The stock has a market capitalization of $32.45 million, a PE ratio of 13.09 and a beta of 0.95. United-Guardian has a one year low of $5.58 and a one year high of $8.45. The business’s fifty day moving average is $7.05 and its 200 day moving average is $6.95.

United-Guardian (NASDAQ:UG) last announced its quarterly earnings data on Friday, August 7th. The company reported $0.16 earnings per share (EPS) for the quarter. United-Guardian had a net margin of 22.01% and a return on equity of 22.24%. The business had revenue of $3.11 million during the quarter.

Institutional Trading of United-Guardian

A number of hedge funds have recently added to or reduced their stakes in the business. Gamco Investors INC. ET AL increased its position in shares of United-Guardian by 1.2% during the first quarter. Gamco Investors INC. ET AL now owns 164,388 shares of the company’s stock worth $1,101,000 after purchasing an additional 1,888 shares in the last quarter. United Capital Financial Advisors LLC purchased a new stake in United-Guardian in the second quarter valued at $143,000. Finally, BlackRock Inc. acquired a new stake in United-Guardian during the second quarter worth about $105,000. 23.16% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Separately, Weiss Ratings restated a “hold (c)” rating on shares of United-Guardian in a research note on Monday, October 19th. One investment analyst has rated the stock with a Hold rating. Based on data from MarketBeat, the stock currently has an average rating of “Hold”.

About United-Guardian

United-Guardian, Inc is a specialty chemicals company that develops, manufactures and markets products for the personal care, pharmaceutical and industrial markets. The company serves customers in the United States and international markets through direct sales, distributors and commercial partners.

Its personal care portfolio includes Lubrajel, a family of water-based moisturizing and lubricating gels used in skin-care, hair-care, cosmetic and personal lubricant formulations. United-Guardian also supplies specialty ingredients designed to improve the texture, moisture retention and performance of finished consumer products.

In the pharmaceutical sector, the company markets Renacidin, a solution used under medical supervision for certain urinary tract applications, including the prevention and dissolution of specific types of urinary encrustations and stones.